Journal
FRONTIERS IN ONCOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2021.804083
Keywords
Epstein-Barr virus; Burkitt lymphoma; malaria; plasma DNA; cell-free DNA
Categories
Funding
- National Cancer Institute, National Institutes of Health [HHSN261200800001E, HHSN261201100063C, HHSN261201100007I]
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Ask authors/readers for more resources
The study found that measuring the plasma EBV DNA copy number in children in Uganda is helpful in diagnosing eBL, and can distinguish between children with eBL and control group children.
Endemic Burkitt lymphoma (eBL) is the most common childhood cancer in regions of equatorial Africa where P. falciparum malaria is holoendemic. The tumor is consistently associated with Epstein-Barr virus (EBV). Screening for EBV DNA in plasma in a high-risk population in Hong Kong has been shown to be useful in facilitating the early diagnosis of nasopharyngeal carcinoma, another EBV-associated tumor. Here, we investigate plasma EBV as a diagnostic marker for eBL in children in Uganda. We studied plasma specimens from 25 children with eBL and 25 controls matched for age (<3-16 years), gender and geography, including many with asymptomatic P. falciparum infection. These specimens were previously collected under the auspices of the EMBLEM (Epidemiology of Burkitt lymphoma in East African children and minors) study. After cell-free DNA isolation, plasma EBV DNA was measured using a quantitative PCR assay that amplifies the large internal repeats of the EBV genome. All children with eBL had measurable plasma EBV, as compared to 84% of control children. The median plasma EBV DNA level was 5.23 log(10) copies/mL (interquartile range 3.54-6.08 log(10) copies/mL) in children with eBL. In contrast, the median plasma EBV DNA level was 0.37 log(10) copies/mL (interquartile range 0.18-1.05 log(10) copies/mL) in children without lymphoma. An EBV threshold of 2.52 log(10) copies/mL yielded a sensitivity of.88 and a specificity of 1. The estimated AUC was 0.936 (95% CI: 0.8496 - 1.00) for the corresponding ROC curve. Plasma EBV copy number did not depend on age, gender, or malaria screening status. However, two control children with asymptomatic P. falciparum infection and parasitemia also had high plasma EBV copy number. Our analysis suggests that measurements of EBV copy number in plasma may be useful in identifying children with eBL versus control children. A promising area for future research is the differentiation of high copy number associated with tumor versus high copy number associated with asymptomatic parasitemia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available